Mycophenolate mofetil treatment in children and adolescents with lupus

Archives of Disease in Childhood

Volumn 95, Issue 12, 2010, Pages 1059-1061

  Kazyra, Ina ^a   Pilkington, Clarissa ^b   Marks, Stephen D ^b   Tullus, Kjell ^b  

^a BELARUSIAN STATE MEDICAL UNIVERSITY   (Belarus)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; HEMOGLOBIN; HYDROXYCHLOROQUINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; ALBUMINURIA; ARTICLE; DISEASE CONTROL; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE SEDIMENTATION RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOCOMPLEMENTEMIA; KIDNEY BIOPSY; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE COUNT; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMPLEMENT C3; COMPLEMENT C4; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MYCOPHENOLIC ACID; PREDNISOLONE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 78649840087     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.178608     Document Type: Article

References (4)

1. Buratti S, Szer IS, Spencer CH, et al. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus. J Rheumatol 2001;28:2103-8.
2. Fu YF, Liu GL. Mycophenolate mofetil therapy for children with lupus nephritis refractory to both intravenous cyclosphosphamide and cyclosporine. Clin Nephrol 2001;55:318-21.
3. Falcini F, Capannini S, Martini G, et al. Mycophenolate mofetil for the treatment of juvenile onset SLE: a multicenter study. Lupus 2009;18:139-43.
4. Fujinaga S, Ohtomo Y, Hara S, et al. Maintenance therapy with mycophenolate mofetil for children with severe lupus nephritis after low-dose intravenous cyclophosphamide regimen. Pediatr Nephrol 2008;23:1877-82